Expanded access experience with anti-CD20 radiolabeled monoclonal antibodies for the treatment of B-cell lymphoma.

被引：0
|
作者：
Dillman, RO
Hurwitz, RR
Lyons, KK
Taketa, RM
Jerjian, KA
Hendrix, C
Holt, A
DeLeon, C
O'Connor, AA
Morrelli, LA
机构：
[1] Hoag Canc Ctr, Newport Beach, CA USA
[2] Hoag Mem Hosp Presbyterian, Newport Beach, CA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4751
引用
收藏
页码：236B / 236B
页数：1
相关论文
共 50 条
  • [11] Anti-CD20 antibodies for primary cutaneous B cell lymphoma. Preliminary results in dermatologic patients
    Gellrich, S
    Muche, JM
    Pelzer, K
    Audring, H
    Sterry, W
    HAUTARZT, 2001, 52 (03): : 205 - 210
  • [12] B-cell subpopulations in humans and their differential susceptibility to depletionwith anti-CD20 monoclonal antibodies
    Maria J Leandro
    Arthritis Research & Therapy, 15
  • [13] B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
    Leandro, Maria J.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15
  • [14] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
  • [15] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
    Abou Mourad, Y
    Taber, A
    Chehal, A
    Shamseddine, A
    ANNALS OF HEMATOLOGY, 2004, 83 (05) : 319 - 321
  • [16] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
    Yasser Abou Mourad
    Ali Taher
    Aref Chehal
    Ali Shamseddine
    Annals of Hematology, 2004, 83 : 319 - 321
  • [17] Interaction of anti-CD20 antibodies and inhibitors of the B-cell receptor pathway in diffuse large B-cell lymphoma
    Peter, N.
    Zoellner, A. K.
    Zimmermann, Y.
    Hutter, G.
    Hiddemann, W.
    Dreyling, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 72 - 72
  • [18] T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma
    Vincent-Salomon, A
    Mathiot, C
    MacIntyre, E
    Girre, V
    Fourquet, A
    Mercier, C
    Fréneaux, P
    Dumont, J
    Decaudin, D
    LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 387 - +
  • [19] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [20] CD20-negative relapse of cutaneous B-cell lymphoma after anti-CD20 monoclonal antibody therapy
    Massengale, WT
    McBurney, E
    Gurtler, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (03) : 441 - 443
12345